A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Conditions
Melanoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ironwood Cancer & Research Centers, Chandler, Arizona, United States
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
Arizona Oncology Associates, Tucson, Arizona, United States
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Providence Medical Foundation, Fullerton, California, United States
Cancer and Blood Specialty Clinic, Los Alamitos, California, United States
University of California Los Angeles, Los Angeles, California, United States
St. Joseph Hospital Orange, Orange, California, United States
University of California Irvine, UCI Medical Center, Orange, California, United States
Eisenhower Medical Center, Rancho Mirage, California, United States
Emad Ibrahim, MD, Inc., Redlands, California, United States
Sutter Health, Sacramento, California, United States
University of California San Francisco (UCSF), San Francisco, California, United States
Sansum Clinic, Santa Barbara, California, United States
St John's Cancer Institute, Santa Monica, California, United States
Rocky Mountain Regional VA Medical Center, Aurora, Colorado, United States
University of Colorado Cancer Center, Aurora, Colorado, United States
The Melanoma And Skin Cancer Institute, Englewood, Colorado, United States
UCHealth, Fort Collins, Colorado, United States
Yale Cancer Center, New Haven, Connecticut, United States
Clermont Oncology Center, Clermont, Florida, United States
Mayo Clinic Florida, Jacksonville, Florida, United States
Cancer Specialist of North Florida, Jacksonville, Florida, United States
Boca Raton Clinical Research (BRCR) Global, Tamarac, Florida, United States
H. Lee Moffitt Cancer Center, Tampa, Florida, United States
University Cancer & Blood Center, Athens, Georgia, United States
John B. Amos Cancer Center, Columbus, Georgia, United States
Beacon Clinic, Coeur d'Alene, Idaho, United States
Hope and Healing Cancer Services, Hinsdale, Illinois, United States
Advocate Lutheran General Hospital, Park Ridge, Illinois, United States
Illinois CancerCare, Peoria, Illinois, United States
Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States
The University of Kansas Cancer Center, Westwood, Kansas, United States
Markey Cancer Center Clinical Research Organization, Lexington, Kentucky, United States
Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States
Maryland Oncology Hematology, P.A., Columbia, Maryland, United States
University of Michigan, Ann Arbor, Michigan, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Henry Ford Cancer Institute/Henry Ford Health System, Detroit, Michigan, United States
Minnesota Oncology Hematology, P.A, Fridley, Minnesota, United States
Allina Health Cancer Institute, Minneapolis, Minnesota, United States
VA St. Louis Healthcare System, St Louis, Missouri, United States
Washington University School of Medicine, St Louis, Missouri, United States
Mercy South, St Louis, Missouri, United States
St. Vincent Healthcare, Billings, Montana, United States
Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha, Nebraska, United States
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
John Theurer Cancer Center, Hackensack, New Jersey, United States
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
The Valley Hospital Inc., Paramus, New Jersey, United States
New York Oncology Hematology, Albany, New York, United States
Messino Cancer Center, Asheville, North Carolina, United States
Levine Cancer Institute, Charlotte, North Carolina, United States
Novant Health Cancer Institute, Charlotte, North Carolina, United States
Novant Health Weisiger Cancer Institute - Charlotte, Charlotte, North Carolina, United States
Duke Health System, Durham, North Carolina, United States
Novant Health Zimmer Cancer Institute - Wilmington, Wilmington, North Carolina, United States
Oncology Hematology Care Clinical Trials, Cincinnati, Ohio, United States
Seidman Cancer Center, Cleveland, Ohio, United States
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa, Oklahoma, United States
USOR Willamette Valley Cancer Institute and Research Center, Eugene, Oregon, United States
Kaiser Foundation Hospitals, Portland, Oregon, United States
Oregon Health and Science University, Portland, Oregon, United States
St. Luke's University Health Network, Easton, Pennsylvania, United States
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Lifespan Cancer Institute, Providence, Rhode Island, United States
Saint Francis Cancer Center, Greenville, South Carolina, United States
Tennessee Oncology - Chattanooga, Chattanooga, Tennessee, United States
University of Tennessee Medical Center, Knoxville, Tennessee, United States
Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville, Tennessee, United States
Tennessee Oncology, Nashville, Tennessee, United States
Texas Oncology - Austin Midtown, Midtown Medical Center I, Austin, Texas, United States
Texas Oncology - Austin Central, Central Austin Cancer Center, Austin, Texas, United States
Texas Oncology - Bedford, Bedford, Texas, United States
Texas Oncology - Medical City, Dallas, Texas, United States
Texas Oncology, Dallas, Texas, United States
Center For Disease And Blood Disorder, Fort Worth, Texas, United States
Texas Oncology - Fort Worth, Fort Worth, Texas, United States
Texas Oncology - Grapevine, Grapevine, Texas, United States
Texas Oncology - Harlingen, Medical Arts Pavillion, Harlingen, Texas, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Texas Oncology - Longview, Longview, Texas, United States
Joe Arrington Cancer Research & Treatment Center, Lubbock, Texas, United States
Texas Oncology - McAllen, McAllen, Texas, United States
Texas Oncology-Palestine Cancer Center, Palestine, Texas, United States
The University of Texas Health Science Center at Tyler D/B/A UT Health East Texas HOPE Cancer Center, Tyler, Texas, United States
Texas Oncology-Tyler, Northeast Texas Cancer Institute, Tyler, Texas, United States
Texas Oncology - Weslaco, Knapp Medical Plaza, Weslaco, Texas, United States
University of Utah Huntsman Cancer Institute, Salt Lake City, Utah, United States
University of Virginia, Charlottesville, Virginia, United States
Inova Schar Cancer Institute, Fairfax, Virginia, United States
Virginia Cancer Specialists, PC, Fairfax, Virginia, United States
Virginia Oncology Associates, Norfolk, Virginia, United States
Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States
Oncology & Hematology Associates of Southwest Virginia, Inc., Roanoke, Virginia, United States
Swedish Cancer Institute - Edmonds Campus, Edmonds, Washington, United States
Swedish Cancer Institute - Issaquah Campus, Issaquah, Washington, United States
Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States
Swedish Cancer Institute, Seattle, Washington, United States
West Virginia University, Morgantown, West Virginia, United States
University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States
Cross Cancer Institute, Edmonton, Alberta, Canada
London Regional Cancer Centre, London, Ontario, Canada
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Jewish General Hospital - Main Address, Montreal, Quebec, Canada
Centre Hospitalier Universitaire de Quebec (CHUQ) - Centre Hospitalier de l'Universite Laval (CHUL), Québec, Canada
Study leads
Clinical Trial Management
Study Director
Regeneron Pharmaceuticals